EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A New Gold(III) Complex, TGS 703, Shows Potent Anti-Inflammatory Activity in Colitis via the Enzymatic and Non-Enzymatic Antioxidant System—An In Vitro, In Silico, and In Vivo Study

Jakub Włodarczyk iD, Julia Krajewska, Łukasz Szeleszczuk iD, Patrycja Szałwińska, Agata Gurba iD, Szymon Lipiec, Przemysław Taciak, Remigiusz Szczepaniak, Izabela Mlynarczuk-Bialy, Jakub Fichna iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24087025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Jakub Włodarczyk und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Medicine, Medical University of Lodz, Mazowiecka 5, 92-215 Lodz, Poland. Hauptthemen laut MEDLINE: Colitis, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Center, Medical University of Lodz.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel diseases (IBD) and their main representatives, Crohn’s disease and ulcerative colitis, are worldwide health-care problems with constantly increasing frequency and still not fully understood pathogenesis. IBD treatment involves drugs such as corticosteroids, derivatives of 5-aminosalicylic acid, thiopurines, and others, with the goal to achieve and maintain remission of the disease. Nowadays, as our knowledge about IBD is continually growing, more specific and effective therapies at the molecular level are wanted. In our study, we tested novel gold complexes and their potential effect on inflammation and IBD in vitro, in silico, and in vivo. A series of new gold(III) complexes (TGS 404, 512, 701, 702, and 703) were designed and screened in the in vitro inflammation studies. In silico modeling was used to study the gold complexes’ structure vs. their activity and stability. Dextran sulphate sodium (DSS)-induced mouse model of colitis was employed to characterize the anti-inflammatory activity in vivo. Lipopolysaccharide (LPS)-stimulated RAW264.7 cell experiments proved the anti-inflammatory potential of all tested complexes. Selected on the bases of in vitro and in silico analyses, TGS 703 significantly alleviated inflammation in the DSS-induced mouse model of colitis, which was confirmed by a statistically significant decrease in the macro- and microscopic score of inflammation. The mechanism of action of TGS 703 was linked to the enzymatic and non-enzymatic antioxidant systems. TGS 703 and other gold(III) complexes present anti-inflammatory potential and may be applied therapeutically in the treatment of IBD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColitisInflammatory Bowel DiseasesAnimalsMiceAntioxidantsGoldAnti-Inflammatory AgentsInflammationDextran SulfateDisease Models, Animal

Stichwörter der Autor:innen

anti-inflammatorygoldinflammatory bowel disease

Substanzen

AntioxidantsGoldAnti-Inflammatory AgentsDextran Sulfate

Autor:innen und Institutionen

  • Department of Biochemistry, Faculty of Medicine, Medical University of Lodz, Mazowiecka 5, 92-215 Lodz, Poland.
  • Department of General and Oncological Surgery, Medical University of Lodz, Pomorska 251, 92-213 Lodz, Poland.
  • Department of Organic and Physical Chemistry, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1, 02-093 Warsaw, Poland.
  • Department of Pharmacodynamics, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1 Str., 02-093 Warsaw, Poland.
  • Department for Histology and Embryology, Medical University of Warsaw, Chalubinskiego 5, 02-004 Warsaw, Poland.
  • Inwex Ltd., Solidarnosci 34, 25-323 Kielce, Poland.

ORCID-Profile: Jakub Włodarczyk, Łukasz Szeleszczuk, Agata Gurba, Jakub Fichna

Förderung

  • National Science Center
  • Medical University of Lodz

Zitieren

APA

Włodarczyk, J., Krajewska, J., Szeleszczuk, Ł., Szałwińska, P., Gurba, A., Lipiec, S., Taciak, P., Szczepaniak, R., Mlynarczuk-Bialy, I., & Fichna, J. (2023). A New Gold(III) Complex, TGS 703, Shows Potent Anti-Inflammatory Activity in Colitis via the Enzymatic and Non-Enzymatic Antioxidant System—An In Vitro, In Silico, and In Vivo Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24087025

Vancouver

Włodarczyk J, Krajewska J, Szeleszczuk Ł, Szałwińska P, Gurba A, Lipiec S, et al. A New Gold(III) Complex, TGS 703, Shows Potent Anti-Inflammatory Activity in Colitis via the Enzymatic and Non-Enzymatic Antioxidant System—An In Vitro, In Silico, and In Vivo Study. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24087025

BibTeX
@article{Wodarczyk2023,
  author = {Włodarczyk, Jakub and Krajewska, Julia and Szeleszczuk, Łukasz and Szałwińska, Patrycja and Gurba, Agata and Lipiec, Szymon and Taciak, Przemysław and Szczepaniak, Remigiusz and Mlynarczuk-Bialy, Izabela and Fichna, Jakub},
  title = {A New Gold(III) Complex, TGS 703, Shows Potent Anti-Inflammatory Activity in Colitis via the Enzymatic and Non-Enzymatic Antioxidant System—An In Vitro, In Silico, and In Vivo Study},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24087025}
}
Kostenlos starten →